Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

被引:36
|
作者
Kristensen, Soren L. [1 ,2 ]
Jhund, Pardeep S. [1 ]
Kober, Lars [3 ]
Preiss, David [1 ]
Kjekshus, John [4 ]
McKelvie, Robert S. [5 ]
Zile, Michael R. [6 ,7 ]
Anand, Inder S. [8 ,9 ]
Wikstrand, John [10 ]
Wedel, Hans [11 ]
Komajda, Michel [12 ,13 ]
Carson, Peter E. [14 ,15 ]
Cleland, John G. F. [16 ,17 ]
McMurray, John J. V. [1 ]
机构
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
[5] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada
[6] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Vet Affairs Med Ctr, Minneapolis, MN USA
[9] Univ Minnesota, Minneapolis, MN USA
[10] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden
[11] Nord Sch Publ Hlth, Gothenburg, Sweden
[12] Univ Paris 06, Hosp Pitie Salpetriere, Paris, France
[13] Inst ICAN, Paris, France
[14] Georgetown Univ, Washington, DC USA
[15] Washington DC Vet Affairs Med Ctr, Washington, DC USA
[16] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[17] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Natl Heart & Lung Inst, London, England
关键词
Heart failure; Clinical trials; HF-PEF; HF-REF; Mortality; ROSUVASTATIN; TRIAL; PROGRESSION; IRBESARTAN; DESIGN; CORONA;
D O I
10.1002/ejhf.211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo investigate the prognostic significance of hospitalization for worsening heart failure (WHF), myocardial infarction (MI), and stroke in patients with chronic heart failure (HF). Methods and resultsWe studied 5011 patients with HF and reduced EF (HF-REF) in the CORONA trial and 4128 patients with HF and preserved EF (HF-PEF) in the I-Preserve trial. Adjusted hazard ratios (HRs) for death were estimated for 0-30 days and 31 days after first post-randomization WHF, MI, or stroke used as a time-dependent variable, compared with patients with none of these events. In CORONA, 1616 patients (32%) had post-randomization first events (1223 WHF, 216 MI, 177 stroke), and the adjusted HR for mortality 30 days after an event was: WHF 7.21 [95% confidence interval (CI) 2.05-25.40], MI 23.08 (95% CI 6.44-82.71), and stroke 32.15 (95% CI 8.93-115.83). The HR for mortality at >30 days was: WHF 3.62 (95% CI 3.11-4.21), MI 4.41 (95% CI 3.23-6.02), and stroke 3.19 (95% CI 2.21-4.61). In I-Preserve, 896 patients (22%) experienced a post-randomization event (638 WHF, 111 MI, 147 stroke). The HR for mortality 30 days was WHF 31.77 (95% CI 7.60-132.81), MI 154.77 (95% CI 34.21-700.17), and stroke 223.30 (95% CI 51.42-969.78); for >30 days it was WHF 3.36 (95% CI 2.79-4.05), MI 3.29 (95% CI 2.14-5.06), and stroke 5.13 (95% CI 3.61-7.29). ConclusionsIn patients with both HF-REF and HF-PEF, hospitalization for WHF was associated with high early and late mortality. The early relative risk of death was not as great as following MI or stroke, but the longer term relative risk of death was similar following all three types of event. Numerically, more deaths occurred following WHF because it was a much more common event.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [41] Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode
    Olivella, Aleix
    Almenar-Bonet, Luis
    Moliner, Pedro
    Coloma, Emmanuel
    Martinez-Rubio, Antoni
    Paz Bermejo, Marco
    Boixeda, Ramon
    Cediel, German
    Mendez Fernandez, Ana Belen
    Facila Rubio, Lorenzo
    ESC HEART FAILURE, 2024, 11 (02): : 628 - 636
  • [42] Predictors of Heart Failure Related Death or Hospitalization in Patients with Heart Failure due to Preserved Ejection Fraction
    Calvin, James E.
    Mangla, Ashvarya
    Beaty, Elijah
    Kane, John
    Richardson, Dejuran
    Powell, Lynda H.
    CIRCULATION, 2012, 126 (21)
  • [43] Managing heart failure with preserved ejection fraction
    Davidson, Alexander
    Raviendran, Nivashinie
    Murali, Charisma Nair
    Myint, Phyo Kyaw
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [44] Myocardial Infarction in Heart Failure With Preserved Ejection Fraction Pooled Analysis of 3 Clinical Trials
    Cunningham, Jonathan W.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    John, Jenine E.
    Desai, Akshay S.
    Lewis, Eldrin F.
    Zile, Michael R.
    Carson, Peter
    Jhund, Pardeep S.
    Kober, Lars
    Pitt, Bertram
    Shah, Sanjiv J.
    Swedberg, Karl
    Anand, Inder S.
    Yusuf, Salim
    McMurray, John J., V
    Pfeffer, Marc A.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2020, 8 (08) : 618 - 626
  • [45] Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
    Talha, Khawaja M.
    Butler, Javed
    CLINICAL CARDIOLOGY, 2022, 45 : S31 - S39
  • [46] ST2 in heart failure with preserved and reduced ejection fraction
    Najjar, Emil
    Faxen, Ulrika Ljung
    Hage, Camilla
    Donal, Erwan
    Daubert, Jean-Claude
    Linde, Cecilia
    Lund, Lars H.
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2019, 53 (01) : 21 - 27
  • [47] Heart Failure with Reduced and Preserved Ejection Fraction: Birds of a Different Feather
    Eyadiel, Lauren S.
    PHYSICIAN ASSISTANT CLINICS, 2025, 10 (02) : 273 - 285
  • [48] Heart Failure with Preserved Ejection Fraction
    Meyer, Adam
    Kerrigan, Martin
    HOSPITAL MEDICINE CLINICS, 2015, 4 (03) : 283 - 296
  • [49] Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction - a secondary analysis of TOPCAT
    Szabo, Barna
    Benson, Lina
    Savarese, Gianluigi
    Hage, Camilla
    Fudim, Marat
    Devore, Adam
    Pitt, Bertram
    Lund, Lars H.
    AMERICAN HEART JOURNAL, 2024, 271 : 136 - 147
  • [50] Heart failure with a preserved ejection fraction
    Warriner, D. R.
    Morris, P. D.
    Saraf, K.
    Al-Mohammad, A.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (02) : C26 - C30